EMCDDA, your reference point on drugs in Europe

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies.

The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.


European Drug Report 2013

28 May 2013: the EMCDDA presents its annual overview of the European drug situation in a new, reshaped information package designed to be more timely, interactive and interlinked.

The package has been designed as a set of integrated elements allowing full access to the available data and analysis on the drugs problem in Europe.